JANE-2

Joint Action on Networks of Expertise on Cancer

Logo der EU-Joint Action JANE2

In November 2024, the Joint Action on Networks of Expertise on Cancer[NG1]  (JANE-2), led by the Istituto Nazionale Tumori in Italy, was launched as a follow-up Joint Action to the Joint Action JANE (2022 – 2024). The aim is to establish seven Networks of Expertise (NoEs) based on Europe's Beating Cancer Plan, with the aim of strengthening collaboration between institutions across Europe through the exchange of expertise. The aim of the networks of expertise is to transfer newly acquired knowledge into clinical application together with service providers and research institutions. Therefore, harmonization with the networking efforts of Europe’s leading cancer centres within the Joint Action EUnetCCC is planned. The NoEs address the following thematic areas: complex cancers with poor prognosis, palliative care, survivorship, personalized primary and secondary prevention, OMICs, high-tech medical resources, and adolescents and young adults with cancer.

DKG is involved in a total of two work packages:

  • Work Package 5 “Complex and poor prognosis cancer”
  • Work Package 7 “Survivorship Networks of Expertise”

DKG is co-leading activity Task 5.6.4 Sustainability as part of Work Package 5 (Network of Expertise for Complex and Poor Prognosis Cancer – NoE PPC). The aim of the activity is to jointly develop a sustainability strategy for the NoE PPC by taking key factors such as resource allocation, funding mechanisms, scalability, cooperation with other EU projects and implementation of the results into account. The Work Package is led by the Polish National Cancer Institute in Warsaw.

In Work Package 7 “Survivorship Networks of Expertise”, led by the Hospital Sant Joan de Déu in Spain, the needs for cancer survivorship programs and guidelines are recorded in several sub-working activities such as the development, implementation and evaluation for the care of cancer survivors within the framework of the expert network are addressed.

Duration

November 2024 – Oktober 2028

More about the project

Participations

Institutions

  • Koordination: Istituto Nazionale Tumori (INT)

Funding

  • Europäische Kommission (EU4Health Programme)

Staff

PD Dr. rer. medic. Christoph Kowalski

PD Dr. rer. medic. Christoph Kowalski

Department Director

Nele Grapentin

Research Associate

expected to be available again in December 2026